Patents Assigned to Premacure AB
  • METHOD AND PRODUCT FOR TREATMENT AND/OR PREVENTION OF COMPLICATIONS OF PREMATURITY
    Publication number: 20130310316
    Abstract: The present invention relates to a composition comprising Insulin Growth Factor I (IGF-I) or an analog thereof in combination with Insulin Growth Factor Binding Protein (IGFBP) or an analog thereof, said combination having a molar ratio of IGF-I to IGFBP being lower than equimolar, preferably in the range from 1:20 to 1:3.33, for use in the treatment of a patient suffering from complications of preterm birth, very preterm birth and/or extremely preterm birth, as well as a method for treating a patient suffering from complications of preterm birth, very preterm birth and/or extremely preterm birth.
    Type: Application
    Filed: July 24, 2013
    Publication date: November 21, 2013
    Applicant: Premacure AB
    Inventors: Ann Hellstrom, Chatarina Lofqvist, Lois Smith
  • Method and product for treatment and/or prevention of complications of prematurity
    Patent number: 8518877
    Abstract: The present invention relates to a composition comprising Insulin Growth Factor I (IGF-I) or an analog thereof in combination with Insulin Growth Factor Binding Protein (IGFBP) or an analog thereof, such combination having a molar ratio of IGF-I to IGFBP being lower than equimolar, preferably in the range from 1:20 to 1:3.33, for use in the treatment of a patient suffering from complications of preterm birth, very preterm birth and/or extremely preterm birth, as well as a method for treating a patient suffering from complications of preterm birth, very preterm birth and/or extremely preterm birth.
    Type: Grant
    Filed: April 18, 2008
    Date of Patent: August 27, 2013
    Assignee: Premacure AB
    Inventors: Ann Hellstrom, Chatarina Lofqvist, Lois Smith
  • METHOD AND PRODUCT FOR TREATMENT AND/OR PREVENTION OF COMPLICATIONS OF PREMATURITY
    Publication number: 20100204101
    Abstract: The present invention relates to a composition comprising Insulin Growth Factor I (IGF-I) or an analog thereof in combination with Insulin Growth Factor Binding Protein (IGFBP) or an analog thereof, said combination having a molar ratio of IGF-I to IGFBP being lower than equimolar, preferably in the range from 1:20 to 1:3.33, for use in the treatment of a patient suffering from complications of preterm birth, very preterm birth and/or extremely preterm birth, as well as a method for treating a patient suffering from complications of preterm birth, very preterm birth and/or extremely preterm birth.
    Type: Application
    Filed: April 18, 2008
    Publication date: August 12, 2010
    Applicant: Premacure AB
    Inventors: Ann Hellstrom, Chatarina Lofqvist, Lois Smith